Sponsor:
Fred Hutchinson Cancer Center
Code:
NCT03399773
Conditions
Acute Biphenotypic Leukemia
Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Hematopoietic and Lymphoid Cell Neoplasm
Myelodysplastic Syndrome
Eligibility Criteria
Sex: All
Age: 10 - 65
Healthy Volunteers: Not accepted
Interventions
Dilanubicel
Cyclophosphamide
Fludarabine
Thiotepa
Total-Body Irradiation
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by Fred Hutchinson Cancer Center on 2025-04-10.